Eucalyptol
Expectorants
Sold as Antispetic · Antiseptic · Tartar control · Original Antiseptic · Tartar control plus
- Drug class
- Expectorants
- Availability
- Over-the-counter
- Routes
- Oral, Rectal
- Markets covered
- 2
- Products on record
- 18
- FDA reports (12 mo)
- 64
Overview
Eucalyptol is an active pharmaceutical ingredient in the Expectorants group (R05CA). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 16 | April 14, 2026 |
| CA Canada | Health Canada | 2 | March 22, 2025 |
USUnited States· FDA
16 products
Uses
Use helps control plaque that leads to gingivitis
How to take
CACanada· Health Canada
2 products
2 products on record with this regulator. Detailed label text (uses, dosage, side effects) is being ingested — the original document is linked under Sources [2].
Sources & citations
- [1]FDA DailyMed · 02ffe892-732b-47… · revised January 29, 2026 [PDF]
- [2]Health Canada (DPD) · 00319716 · revised March 22, 2025
- [3]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.